Alnylam Drug Approval Brings Cardiomyopathy Competition to Pfizer, BridgeBio Pharma

Amvuttra, an Alnylam drug approved to treat nerve pain from transthyretin amyloidosis, is now FDA-approved for treating cardiomyopathy caused by this disease. The approval brings Amvuttra to a much bigger market, but it must compete with a blockbuster Pfizer drug already established as the standard of care. The post Alnylam Drug Approval Brings Cardiomyopathy Competition…

Read More

Sibel Health Rakes In $30M for Its Wearable-Based RPM Platform

Sibel Health raised $30 million to accelerate the commercial deployment of its remote patient monitoring platform. The company also announced its seventh FDA clearance, which enables clinicians to use alarms and alerts along with the Sibel’s central platform. The post Sibel Health Rakes In $30M for Its Wearable-Based RPM Platform appeared first on MedCity News.

Read More

Women’s History Month Spotlight: Maria Tabarez

Maria Tabarez, Director of Facilities, Exodus Recovery Safe Landing Maria Tabarez has an unusual job: maintaining, cleaning, and disinfecting a 172-bed homeless shelter.  The challenges of keeping the five-building facility clean and disinfected 24/7 present challenges unlike most other Crothall facilities. Some residents who come to Exodus Recovery Safe Landing in Los Angeles have more…

Read More